http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011138956-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e5c121269689cbab9b3a4548b15caf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d521adb3194c1bab702429899d3ca7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_087dda0c795ee46c26a1c32802d75e1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b13caf55578dea0e63a6d691c39e146a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efd5c98ae8aedab7b0f26d2290fa9f83
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2011-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f996fe0efb044618088cde849f7437f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30f13b3512809c58081e54fd67916eca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e7cee85e4e227b92b8e55436ca6097c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49f23216183d55fd193c10a3aa4200be
publicationDate 2011-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2011138956-A1
titleOfInvention Novel prenylarene compound and use thereof
abstract Disclosed is a compound shown by general formula (C) having hypoxic environment selective growth inhibiting activity in a wide range of concentrations and having usefulness as an active ingredient in a preventative or therapeutic drug for cancer or a pharmaceutically acceptable salt thereof. (In the formula, R 101 represents an optionally substituted heteroaromatic ring group. R 102 , R 103 , R 104 , and R 105 are the same or different and represent hydrogen atoms, halogen atoms, C 1-3 alkyl groups, or C 1-3 haloalkyl groups. R 106 represents a hydrogen atom, or a C 1-12 straight chain or branched chain, saturated or unsaturated hydrocarbon group. Here, cases where R 101 is a 3-furyl group, where all of R 102 , R 103 , R 104 , and R 105 are methyl groups, and where R 106 is a methyl group, 4-methyl-3-pentenyl group, or 4,8-dimethyl-3,7-nonadienyl group are excluded.)
priorityDate 2010-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127386326
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54170124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128343330
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128863330

Total number of triples: 36.